Posttransplant diabetes mellitus after pancreas transplantation

P. G. Dean, Yogish C Kudva, T. S. Larson, Walter K Kremers, Mark D Stegall

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Some patients do not achieve normoglycemia after an otherwise successful pancreas transplant. The aim of this study was to define the incidence and risk factors for the development of persistent diabetes mellitus after pancreas transplantation. We studied the outcomes of 144 pancreas transplants performed at our institution between January 2001 and December 2005. Diabetes mellitus was defined as the persistent need for pharmacologic treatment of diabetes mellitus despite evidence of allograft function. Data are expressed as median (25-75% inter-quartile range). Median follow-up was 39 months (IQR 26-55 months). During the follow-up period, 28 patients (19%) developed diabetes mellitus with a functioning allograft. Factors predicting hyperglycemia included: pretransplant insulin dose, BMI and acute rejection episodes (p < 0.0001, p = 0.0002 and p < 0.02, respectively). The median pretransplant hemoglobin A1c for patients developing diabetes was 8.3% (IQR 7.0-9.4%) compared to 6.2% (IQR 5.8-7.4%) at 2 years after transplant (p = 0.0069). In conclusion, persistent diabetes mellitus can occur despite the presence of a functioning pancreas allograft and is due to increased pretransplant BMI, high pretransplant insulin requirements and episodes of acute rejection.

Original languageEnglish (US)
Pages (from-to)175-182
Number of pages8
JournalAmerican Journal of Transplantation
Volume8
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Pancreas Transplantation
Diabetes Mellitus
Allografts
Pancreas
Transplants
Insulin
Hyperglycemia
Hemoglobins
Incidence

Keywords

  • Clinical pancreas transplantation
  • Complications
  • Type 1 diabetes mellitus
  • Type 2 diabetes

ASJC Scopus subject areas

  • Immunology

Cite this

Posttransplant diabetes mellitus after pancreas transplantation. / Dean, P. G.; Kudva, Yogish C; Larson, T. S.; Kremers, Walter K; Stegall, Mark D.

In: American Journal of Transplantation, Vol. 8, No. 1, 01.2008, p. 175-182.

Research output: Contribution to journalArticle

@article{bde7dda88a0d45bc84ae7d4d6f4e52f0,
title = "Posttransplant diabetes mellitus after pancreas transplantation",
abstract = "Some patients do not achieve normoglycemia after an otherwise successful pancreas transplant. The aim of this study was to define the incidence and risk factors for the development of persistent diabetes mellitus after pancreas transplantation. We studied the outcomes of 144 pancreas transplants performed at our institution between January 2001 and December 2005. Diabetes mellitus was defined as the persistent need for pharmacologic treatment of diabetes mellitus despite evidence of allograft function. Data are expressed as median (25-75{\%} inter-quartile range). Median follow-up was 39 months (IQR 26-55 months). During the follow-up period, 28 patients (19{\%}) developed diabetes mellitus with a functioning allograft. Factors predicting hyperglycemia included: pretransplant insulin dose, BMI and acute rejection episodes (p < 0.0001, p = 0.0002 and p < 0.02, respectively). The median pretransplant hemoglobin A1c for patients developing diabetes was 8.3{\%} (IQR 7.0-9.4{\%}) compared to 6.2{\%} (IQR 5.8-7.4{\%}) at 2 years after transplant (p = 0.0069). In conclusion, persistent diabetes mellitus can occur despite the presence of a functioning pancreas allograft and is due to increased pretransplant BMI, high pretransplant insulin requirements and episodes of acute rejection.",
keywords = "Clinical pancreas transplantation, Complications, Type 1 diabetes mellitus, Type 2 diabetes",
author = "Dean, {P. G.} and Kudva, {Yogish C} and Larson, {T. S.} and Kremers, {Walter K} and Stegall, {Mark D}",
year = "2008",
month = "1",
doi = "10.1111/j.1600-6143.2007.02018.x",
language = "English (US)",
volume = "8",
pages = "175--182",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Posttransplant diabetes mellitus after pancreas transplantation

AU - Dean, P. G.

AU - Kudva, Yogish C

AU - Larson, T. S.

AU - Kremers, Walter K

AU - Stegall, Mark D

PY - 2008/1

Y1 - 2008/1

N2 - Some patients do not achieve normoglycemia after an otherwise successful pancreas transplant. The aim of this study was to define the incidence and risk factors for the development of persistent diabetes mellitus after pancreas transplantation. We studied the outcomes of 144 pancreas transplants performed at our institution between January 2001 and December 2005. Diabetes mellitus was defined as the persistent need for pharmacologic treatment of diabetes mellitus despite evidence of allograft function. Data are expressed as median (25-75% inter-quartile range). Median follow-up was 39 months (IQR 26-55 months). During the follow-up period, 28 patients (19%) developed diabetes mellitus with a functioning allograft. Factors predicting hyperglycemia included: pretransplant insulin dose, BMI and acute rejection episodes (p < 0.0001, p = 0.0002 and p < 0.02, respectively). The median pretransplant hemoglobin A1c for patients developing diabetes was 8.3% (IQR 7.0-9.4%) compared to 6.2% (IQR 5.8-7.4%) at 2 years after transplant (p = 0.0069). In conclusion, persistent diabetes mellitus can occur despite the presence of a functioning pancreas allograft and is due to increased pretransplant BMI, high pretransplant insulin requirements and episodes of acute rejection.

AB - Some patients do not achieve normoglycemia after an otherwise successful pancreas transplant. The aim of this study was to define the incidence and risk factors for the development of persistent diabetes mellitus after pancreas transplantation. We studied the outcomes of 144 pancreas transplants performed at our institution between January 2001 and December 2005. Diabetes mellitus was defined as the persistent need for pharmacologic treatment of diabetes mellitus despite evidence of allograft function. Data are expressed as median (25-75% inter-quartile range). Median follow-up was 39 months (IQR 26-55 months). During the follow-up period, 28 patients (19%) developed diabetes mellitus with a functioning allograft. Factors predicting hyperglycemia included: pretransplant insulin dose, BMI and acute rejection episodes (p < 0.0001, p = 0.0002 and p < 0.02, respectively). The median pretransplant hemoglobin A1c for patients developing diabetes was 8.3% (IQR 7.0-9.4%) compared to 6.2% (IQR 5.8-7.4%) at 2 years after transplant (p = 0.0069). In conclusion, persistent diabetes mellitus can occur despite the presence of a functioning pancreas allograft and is due to increased pretransplant BMI, high pretransplant insulin requirements and episodes of acute rejection.

KW - Clinical pancreas transplantation

KW - Complications

KW - Type 1 diabetes mellitus

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=37549050192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549050192&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2007.02018.x

DO - 10.1111/j.1600-6143.2007.02018.x

M3 - Article

C2 - 17973965

AN - SCOPUS:37549050192

VL - 8

SP - 175

EP - 182

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 1

ER -